An important role of lymphatic vessel activation in limiting acute inflammation
Top Cited Papers
Open Access
- 28 April 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 117 (17), 4667-4678
- https://doi.org/10.1182/blood-2010-10-316356
Abstract
In contrast to the established role of blood vessel remodeling in inflammation, the biologic function of the lymphatic vasculature in acute inflammation has remained less explored. We studied 2 established models of acute cutaneous inflammation, namely, oxazolone-induced delayed-type hypersensitivity reactions and ultraviolet B irradiation, in keratin 14-vascular endothelial growth factor (VEGF)-C and keratin 14-VEGF-D transgenic mice. These mice have an expanded network of cutaneous lymphatic vessels. Transgenic delivery of the lymphangiogenic factors VEGF-C and the VEGFR-3 specific ligand mouse VEGF-D significantly limited acute skin inflammation in both experimental models, with a strong reduction of dermal edema. Expression of VEGFR-3 by lymphatic endothelium was strongly down-regulated at the mRNA and protein level in acutely inflamed skin, and no VEGFR-3 expression was detectable on inflamed blood vessels and dermal macrophages. There was no major change of the inflammatory cell infiltrate or the composition of the inflammatory cytokine milieu in the inflamed skin of VEGF-C or VEGF-D transgenic mice. However, the increased network of lymphatic vessels in these mice significantly enhanced lymphatic drainage from the ear skin. These results provide evidence that specific lymphatic vessel activation limits acute skin inflammation via promotion of lymph flow from the skin and reduction of edema formation.Keywords
This publication has 51 references indexed in Scilit:
- Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammationThe Journal of Experimental Medicine, 2010
- Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-κB and Prox1Blood, 2010
- Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasisProceedings of the National Academy of Sciences of the United States of America, 2009
- Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritisArthritis & Rheumatism, 2009
- Transgenic Induction of Vascular Endothelial Growth Factor-C Is Strongly Angiogenic in Mouse Embryos but Leads to Persistent Lymphatic Hyperplasia in Adult TissuesThe American Journal of Pathology, 2008
- Deletion of Vascular Endothelial Growth Factor C (VEGF-C) and VEGF-D Is Not Equivalent to VEGF Receptor 3 Deletion in Mouse EmbryosMolecular and Cellular Biology, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodesBlood, 2007
- Vascular Endothelial Growth Factor-A Mediates Ultraviolet B-Induced Impairment of Lymphatic Vessel FunctionThe American Journal of Pathology, 2006
- Peroxiredoxin 6 Is a Potent Cytoprotective Enzyme in the EpidermisThe American Journal of Pathology, 2006